Balancing Sustainable Growth with a Sustainable Society Through MANI Sustainability
First written in FY2022-Q1. 1 of 4 entries say "Reframed", first in FY2023. Latest entry: 2026-04-24.
- 2026-04-24Cited as achievedOther Disclosures
「In this assessment, the social value of our product portfolio, our initiatives concerning product safety and governance, and the progress made in information disclosure were recognized, leading to our receiving a “Prime Status” rating in the “Medical Devices and Medical Supplies” industry.」
The initial “Prime Status” recognition by ISS ESG provides external recognition of progress in sustainability initiatives, product safety, governance, and information disclosure. - FY2025AdvancedAnnual report
「Beginning with the fiscal year ending August 2026, the Company established a Sustainability Committee and began its activities to promote sustainability across the Company.」
Beginning with the fiscal year ending August 2026, the Company has moved to an operating structure under which the Sustainability Committee monitors KPI progress and reports regularly to the Board of Directors. - FY2023ReframedAnnual report
「Below, we describe the details of each of the 4 areas recommended by the TCFD Recommendations: ① governance, ② strategy, ③ risk management, and ④ metrics and targets.」
The Company has developed MANI Sustainability into a disclosure framework aligned with the 4 TCFD areas of governance, strategy, risk management, and metrics and targets. - FY2022-Q1First statedAnnual report
「In addition, to balance the Group's sustainable growth with a sustainable society, we have established MANI Sustainability」
The Company has, for the first time, set out a policy of establishing MANI Sustainability to balance sustainable growth with a sustainable society.